SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:gup.ub.gu.se/139993"
 

Sökning: onr:"swepub:oai:gup.ub.gu.se/139993" > Child health, devel...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003356naa a2200481 4500
001oai:gup.ub.gu.se/139993
003SwePub
008240528s2011 | |||||||||||000 ||eng|
024a https://gup.ub.gu.se/publication/1399932 URI
024a https://doi.org/10.1210/er.2009-00392 DOI
040 a (SwePub)gu
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a for2 swepub-publicationtype
100a Hochberg, Z.4 aut
2451 0a Child health, developmental plasticity, and epigenetic programming
264 c 2010-10-22
264 1b The Endocrine Society,c 2011
520 a Plasticity in developmental programming has evolved in order to provide the best chances of survival and reproductive success to the organism under changing environments. Environmental conditions that are experienced in early life can profoundly influence human biology and long-term health. Developmental origins of health and disease and life-history transitions are purported to use placental, nutritional, and endocrine cues for setting long-term biological, mental, and behavioral strategies in response to local ecological and/or social conditions. The window of developmental plasticity extends from preconception to early childhood and involves epigenetic responses to environmental changes, which exert their effects during life-history phase transitions. These epigenetic responses influence development, cell- and tissue-specific gene expression, and sexual dimorphism, and, in exceptional cases, could be transmitted transgenerationally. Translational epigenetic research in child health is a reiterative process that ranges from research in the basic sciences, preclinical research, and pediatric clinical research. Identifying the epigenetic consequences of fetal programming creates potential applications in clinical practice: the development of epigenetic biomarkers for early diagnosis of disease, the ability to identify susceptible individuals at risk for adult diseases, and the development of novel preventive and curative measures that are based on diet and/or novel epigenetic drugs.
700a Feil, R.4 aut
700a Constancia, M.4 aut
700a Fraga, M.4 aut
700a Junien, C.4 aut
700a Carel, J. C.4 aut
700a Boileau, P.4 aut
700a Le Bouc, Y.4 aut
700a Deal, C. L.4 aut
700a Lillycrop, K.4 aut
700a Scharfmann, R.4 aut
700a Sheppard, A.4 aut
700a Skinner, M.4 aut
700a Szyf, M.4 aut
700a Waterland, R. A.4 aut
700a Waxman, D. J.4 aut
700a Whitelaw, E.4 aut
700a Ong, K.4 aut
700a Albertsson-Wikland, Kerstin,d 1947u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för pediatrik,Institute of Clinical Sciences, Department of Pediatrics4 aut0 (Swepub:gu)xalbke
710a Göteborgs universitetb Institutionen för kliniska vetenskaper, Avdelningen för pediatrik4 org
773t Endocrine reviewsd : The Endocrine Societyg 32:2, s. 159-224q 32:2<159-224x 0163-769Xx 1945-7189
856u https://academic.oup.com/edrv/article-pdf/32/2/159/8858124/edrv0159.pdf
8564 8u https://gup.ub.gu.se/publication/139993
8564 8u https://doi.org/10.1210/er.2009-0039

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy